More on Lialda ruling


Actavis (ACT) confirms the reversal of the U.S. District Court of the Southern District of Florida ruling that the firm's generic mesalamine infringes on a Lialda patent.

The U.S. Court of Appeals found that the District Court failed to correctly interpret the claims of the '720 patent. It remands the case back to the District Court for further proceedings based on the Appeals Court's rulings.

Shire plc (SHPG) finished today's trading down 1% at $149.67.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs